Profile
Christopher Beck is Senior Vice President-Operations at Context Therapeutics, Inc. since 2022.
Former positions include Vice President-Program Management at Galera Therapeutics, Inc., Aevi Genomic Medicine, Inc., and Formular Pharmaceuticals, Inc. Education includes an undergraduate degree from Drexel University and an MBA from The Pennsylvania State University.
Christopher Beck active positions
| Companies | Position | Start |
|---|---|---|
| CONTEXT THERAPEUTICS INC. | Chief Operating Officer | 2022-01-04 |
Former positions of Christopher Beck
| Companies | Position | End |
|---|---|---|
| AEVI GENOMIC MEDICINE, INC. | Corporate Officer/Principal | - |
Formular Pharmaceuticals, Inc. | Corporate Officer/Principal | - |
| GALERA THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Training of Christopher Beck
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Galera Therapeutics, Inc.
Galera Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes drugs to reduce normal tissue toxicity from radiotherapy | Health Technology |
Drexel University
Drexel University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Pennsylvania State University
The Pennsylvania State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aevi Genomic Medicine, Inc.
Aevi Genomic Medicine, Inc. Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of treatments for auto-immune pediatric disease | Health Technology |
Context Therapeutics, Inc.
Context Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which develops treatment options for women living with hormone-dependent cancer | Health Technology |
Formular Pharmaceuticals, Inc. |
- Stock Market
- Insiders
- Christopher Beck
















